Pharma firms win big as Singapore boosts public healthcare spending

Pharma spending could hit US$1.26b by 2022 amidst a boost in government spending.

Increased government spending will sustain the rapid growth of Singapore's pharmaceutical market, a report by Fitch Solutions revealed.

Additional resources in the 2018 budget are geared towards the consolidation of health and social services, as there are currently almost half a million people aged over 65 in the country.

"To this end, Singapore’s healthcare and pharmaceutical market will experience robust growth driven by the country's concerted effort to improve the health and well-being of its elderly population," the report noted.

The country's pharmaceutical market was valued at US$880m (S$1.22b) in 2017. It is expected to hit US$1.26b (S$1.56b) by 2022.

“Amidst an ageing population, the Singapore government increasingly focused on ensuring that healthcare spending is kept affordable for the citizens, and we expect the future launch of the ‘Merdeka Generation Package’ to put upside pressure on overall fiscal expenditures,” the report noted.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit